[1]
J. Pietrzykowska, “Significance of zoledronic acid in the adjuvant therapy in patients with breast cancer”, Pol J Public Health, vol. 134, pp. 37–41, Jul. 2024, doi: 10.12923/2083-4829/2024-0009.